Brief: Bio Vitos Pharma To Divest Business, Purchase Price SEK 400,000

Bio Vitos Pharma AB

11/11/2024 12:45

Nov 11 (Reuters) - Bio Vitos Pharma AB  BIOVIT.ST :
    * SIGNS AGREEMENT TO DIVEST BUSINESS
    * HAS ENTERED INTO AN AGREEMENT TO DIVEST HEMCHECK
MANAGEMENT AB
    * THE PURCHASE PRICE IS SEK 400,000 WITH AN ADDITION FOR
WORKING
CAPITAL EXCLUDING INVENTORY
    * THE BUYER IS JAE A CONSULTING AB

Source text:  ID:nWkr4L3NSt 
Further company coverage:  BIOVIT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))